Grants for State governments - Health

The 2024 Choose Henry Fund-Community Grants, offered by the Henry County Community Foundation (HCCF), aim to address the broad needs of Henry County, Indiana. As a community foundation, HCCF's mission is to support diverse areas within the county, including health and medical, social services, education, cultural affairs, and civic affairs. This grant program is aligned with the foundation's overall mission to be responsive to changing community needs, be flexible, and focus on projects with the greatest benefit per dollar granted. The target beneficiaries of these grants are non-profit organizations serving Henry County, specifically those that have been selected through a letter of intent process. The impact goals are to support various programs and facilities that improve the quality of life within the county across the five key areas of interest. This includes, but is not limited to, supporting hospitals and rehabilitation centers, human service organizations, programs for children, youth, and the aged, educational initiatives from pre-school to post-secondary, cultural programs, and civic activities related to criminal justice, community development, and leadership training. The HCCF prioritizes change-oriented and problem-solving initiatives, emphasizing project support rather than ongoing general operating support. The foundation also encourages participation from other contributors through matching challenges and other grant techniques. Additionally, the HCCF aims to coordinate its programs with other funding sources, such as government, other foundations, and associations, to maximize impact. A key focus is to induce grant recipients to achieve objectives like increased efficiency, improved fundraising capabilities, and enhanced product or service delivery. Expected outcomes and measurable results are implicitly tied to the grant evaluation criteria. The foundation assesses whether there is an established need for the requested program or project, its appropriateness for HCCF funding, the adequacy of HCCF resources to respond, and the overall benefit to the community. While specific metrics are not explicitly detailed, the focus on "greatest benefit per dollar granted" and inducing recipients to improve efficiency and service delivery suggests an emphasis on demonstrable positive change and effective resource utilization within Henry County.

This funding opportunity supports research projects that analyze existing national data to improve healthcare access and outcomes for children and adolescents with autism and developmental disabilities, particularly in underserved populations.

This FOA invites applications that propose research projects that test promising digital healthcare interventions aimed at improving quality of care and healthcare services delivery at the point of care. This FOA will use the Phased Innovation Award (R21/R33) mechanism to provide up to 2 years of R21 support for initial developmental activities, and up to 3 years of R33 support for expanded activities.The Agency for Healthcare Research and Quality's (AHRQ) mission is to produce evidence to make health care safer, of higher quality, more accessible, equitable, and affordable, and to work within the U.S. Department of Health and Human Services and with other partners to make sure that the evidence is understood and used. This FOA invites applications that propose research projects that test promising digital healthcare interventions aimed at improving quality of care and healthcare services delivery at the point of care. This FOA will use the Phased Innovation Award (R21/R33) mechanism to provide up to 2 years of R21 support for initial developmental activities, and up to 3 years of R33 support for expanded activities. Transition to the R33 phase is not guaranteed for all grants awarded under this FOA. Continuation from the R21 phase to the R33 phase will be determined by AHRQ staff based on progress achieved in the R21 phase and factors such as program priorities and availability of funds.

The National Eye Institute (NEI) supports investigator-initiated, complex, multi-center and other high resource risk epidemiologic studies under the cooperative agreement mechanism, UG1 activity code. Specifically, the purpose of this Funding Opportunity Announcement (FOA) is to support new and innovative ocular epidemiology research.The purpose of this Funding Opportunity Announcement (FOA) is to support epidemiologic studies that utilize creative and innovative approaches to studying vision diseases and disorders with high public impact and whose findings will inform prevention and treatment strategies as well as basic sciences research. Background: Clinical vision research projects, including epidemiologic studies, are part of NEI’s core strategy for improving visual health and decreasing visual impairment in populations through research on the burden of disease, its causes, diagnosis, prevention, treatment and rehabilitation. Projects should focus on NEI’s mission to protect and improve visual health including, but not limited to: Determining the burden of eye diseases and their visual outcomes in a changing population, particularly disparities in the burden and the influences of sociocultural, environmental, economic, and demographic factors. Improving early diagnosis of ocular diseases and their underlying processes through new screening and detection strategies. Determining risk factors for ocular diseases. Identifying and assessing strategies that will overcome barriers to eye care and convert evidence-based findings into improved patient and population outcomes. Studying the interplay of factors that exacerbate or mitigate risk for eye diseases. The NEI encourages applications to support ocular epidemiologic research. These projects are supported under the cooperative agreement mechanism. Applicants are strongly encouraged to contact Scientific/Research staff as plans for an application are being developed (see Section VII, Agency Contacts), preferably no later than 12 weeks prior to the anticipated application submission date.

The "Innovative Molecular and Cellular Analysis Technologies for Basic and Clinical Cancer Research" grant aims to fund exploratory research projects that focus on the development of innovative technologies for analyzing molecular or cellular aspects of cancer, with the goal of improving cancer biology research, early detection, diagnosis, treatment, control, epidemiology, and addressing health disparities related to cancer.

The National Institutes of Health (NIH) has announced a funding opportunity titled Co-infection and Cancer (R01 Clinical Trial Not Allowed) under Funding Opportunity Number PAR-25-082. This initiative, led by the National Cancer Institute (NCI), is aimed at advancing research into the roles of co-infection in cancer development and progression. Co-infection is defined as the occurrence of two or more infections, whether simultaneous or sequential, involving pathogens or non-pathogenic agents, including viruses, bacteria, and parasites. The goal of this program is to explore how these co-infections contribute to cancer risk and progression and identify potential strategies for cancer prevention and treatment. The program encourages investigations that focus on co-infections with known oncogenic agents, excluding human immunodeficiency virus (HIV), and seeks studies that can lead to new opportunities in cancer treatment and prevention. In addition to pathogenic agents, research that includes the role of non-pathogenic agents, such as those in the microbiome, will be considered responsive. The program supports projects that delve into uncharted areas of co-infection and cancer, with an emphasis on mechanistic and epidemiologic research that could have practical implications for cancer control. Applicants are encouraged to focus on differences in cancer susceptibility, progression, and survival among diverse populations, including those that are racially or ethnically diverse, as well as medically underserved communities. International collaborations are also supported, particularly for studies in low- and middle-income countries where infection-associated cancers are more prevalent. The first submission date is January 5, 2025, with application due dates beginning on February 5, 2025. Budgets are not limited but must align with the scope of the project, and the maximum project period is five years. Applications must be submitted electronically through NIH's ASSIST system or Grants.gov. Eligible applicants include higher education institutions, nonprofits, for-profit organizations, and foreign entities. The program seeks to support well-developed research projects backed by preliminary data. Studies that focus solely on co-infection with HIV or involve only a single pathogen will not be considered responsive. Evaluation criteria include the scientific merit of the project, innovation, and feasibility, as well as the expertise of the research team. This funding opportunity offers a unique chance to explore how co-infections contribute to cancer and potentially uncover new strategies for prevention and treatment across diverse populations.

This funding opportunity supports research that provides critical data to help the FDA regulate tobacco products, targeting a wide range of organizations, including nonprofits, educational institutions, and community groups, to improve public health outcomes related to tobacco use.

This funding opportunity supports innovative researchers in the U.S. who are tackling significant challenges in diabetes, metabolic diseases, digestive disorders, and nutrition, with the goal of advancing groundbreaking scientific understanding and treatment.

The Southern Sustainable Agriculture Research & Education (SSARE) Education Grants program is designed to fund education and outreach activities that benefit the sustainable agriculture community. This grant directly aligns with SSARE's mission to promote efforts in farmer innovations, community resilience, business success, agricultural diversification, and best management practices. The core objective is to support projects that develop sustainable agriculture systems or move existing systems towards sustainability. The primary beneficiaries of these grants are farmers and farming communities, including those involved in indigenous agriculture producing for community food systems. Academic institutions, non-profits, non-governmental organizations (NGOs), 1890 land-grant university faculty/extension cooperators, 1862 land-grant universities, other colleges and universities, and government agencies are eligible to apply, acting as facilitators for these educational initiatives. The impact goals are centered on fostering a more sustainable, resilient, and economically viable agricultural sector through knowledge dissemination and practical application. Education Grants prioritize projects that clearly articulate what is being taught, to whom, and how the goals will be accomplished. Focus areas include experiential learning (demonstrations, on-farm tours, field days, workshops), integrative approaches (conferences, seminars, course curriculum), and reinforcement methods (fact sheets, bulletins, videos, online technologies). SSARE also encourages proposals on quality of life topics, such as heirs property, farmers’ markets, food hubs, local/regional processing, and urban agriculture systems, emphasizing the social health of farming systems. Expected outcomes include the adoption of sustainable agriculture practices, enhanced farmer innovation, increased community resilience, improved business success for agricultural enterprises, and greater agricultural diversification. Projects should yield results that are realistic, acceptable to farmers, logical, and capable of leading to tangible actions and benefits described in the proposal. The grant projects are strictly focused on education and outreach, with no research component, and are paid by reimbursement of allowable expenses. The foundation's strategic priorities are evident in the grant requirements, which mandate that project outcomes focus on sustainable agriculture systems and clearly demonstrate how education and outreach efforts will be implemented and evaluated. The theory of change underpinning this program is that by providing targeted education and outreach, knowledge and best practices will be transferred to farmers and communities, leading to the development and widespread adoption of sustainable agricultural methods and improved quality of life within farming systems. Project maximums are $50,000, with a duration limited to two years. Applicants from the Southern region, including Alabama, Arkansas, Florida, Georgia, Kentucky, Louisiana, Mississippi, North Carolina, Oklahoma, South Carolina, Tennessee, Texas, Virginia, Puerto Rico, and the U.S. Virgin Islands, are eligible. Farmers involved in these projects must have farming/ranching as their primary occupation or part-time farming with at least $1,000 of documented annual income from their operation, with exceptions for indigenous agriculture.

This funding opportunity supports postdoctoral researchers from underrepresented groups in cancer research as they transition to independent faculty positions, providing salary and research funding to help establish their own research programs.

This funding opportunity supports organizations that provide training for mental health paraprofessionals to enhance their skills in serving children and youth at risk for behavioral health issues.

This funding opportunity supports innovative clinical research to explore the brain mechanisms behind substance use disorders, targeting a wide range of researchers and institutions dedicated to addressing addiction challenges.

The National Institute on Drug Abuse (NIDA) Cutting-Edge Basic Research Award (CEBRA) is designed to foster highly innovative or conceptually creative research related to the etiology, pathophysiology, prevention, or treatment of substance use disorders (SUDs). It supports high-risk and potentially high-impact research that is underrepresented or not included in NIDA's current portfolio that has the potential to transform SUD research. The proposed research should: 1. develop, and/or adapt, revolutionary techniques or methods for addiction research or that show promising future applicability to SUD research; and /or 2. test an innovative and significant hypothesis for which there are scant precedent or preliminary data and which, if confirmed, would transform current thinking.

This funding opportunity provides financial support for researchers to analyze and integrate existing data to better understand cancer risk, prevention, and treatment outcomes, particularly focusing on innovative methodologies and addressing health disparities.

This funding opportunity supports clinical research projects that extend or enhance existing breast cancer studies, requiring collaboration with consumer advocates to improve outcomes for patients and the community.

This funding opportunity supports multidisciplinary research aimed at improving the understanding and treatment of asthma and allergic diseases, inviting applications from various institutions and organizations involved in clinical and translational research.

This grant provides funding to specialized clinics for collecting and analyzing long-term health data on individuals with spina bifida, aiming to improve care and health outcomes for patients of all ages.

This funding opportunity supports innovative research projects that explore how T-cells contribute to HIV infection and related brain complications, targeting researchers from various institutions and organizations.

This funding opportunity supports innovative educational projects that engage K-12 students and teachers in the biomedical and behavioral sciences, particularly targeting individuals from diverse and underrepresented backgrounds.

The purpose of the Paul Calabresi Career Development Award for Clinical Oncology (PCACO) is to increase the number of clinician-scientists trained in clinical and translational cancer research, and to promote their career development as cancer researchers. This Funding Opportunity Announcement (FOA) allows appointment of Scholars proposing to serve as the lead investigator of an independent clinical trial; or proposing a separate ancillary study to an existing trial; or proposing to gain research experience in a clinical trial led by another investigator, as part of their research and career development.